EP 1036171 A2 20000920 - MOLECULES INTERACTING WITH APOPTIN
Title (en)
MOLECULES INTERACTING WITH APOPTIN
Title (de)
MOLEKULEN INTERAGIEREND MIT APOPTIN
Title (fr)
MOLECULES AYANT UNE INTERACTION AVEC L'APOPTINE
Publication
Application
Priority
- EP 98958401 A 19981203
- EP 97203781 A 19971203
- NL 9800687 W 19981203
Abstract (en)
[origin: EP0921192A1] The invention relates to activation of apoptosis by means of interference of Hou-like and/or IFP35-like compounds. Also the invention relates to anti-tumor therapies with compounds, which negatively interfere with Hou-like and/or IFP35-like compounds leading to induction of apoptosis, resulting in the elimination of tumor cells. Also the invention relates to therapies for diseases related to aberrant apoptosis induction, such as auto-immune disease. Also the invention describes the diagnosis of cells, which are susceptible to apoptin- or apoptin-like induced apoptosis.
IPC 1-7
C12N 15/12; C07K 14/47; A61K 38/17; C12Q 1/68; C12N 1/19; C12N 1/21
IPC 8 full level
A61K 38/17 (2006.01); C07K 14/47 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 15/12 (2006.01); C12Q 1/68 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP)
A61P 35/00 (2017.12); C07K 14/4702 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
See references of WO 9928460A2
Designated contracting state (EPC)
AT BE CH DE ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
EP 0921192 A1 19990609; AU 1446099 A 19990616; AU 761037 B2 20030529; CA 2311611 A1 19990610; EP 1036171 A2 20000920; NZ 504952 A 20030725; WO 9928460 A2 19990610; WO 9928460 A3 19990812
DOCDB simple family (application)
EP 97203781 A 19971203; AU 1446099 A 19981203; CA 2311611 A 19981203; EP 98958401 A 19981203; NL 9800687 W 19981203; NZ 50495298 A 19981203